- Recent Funding
- Investors
- Lightstone Ventures
Lightstone Ventures portfolio
Lightstone Ventures has 4 portfolio companies on record at Recent Funding, with 2 investments in the last 12 months.
About this page
It is a venture capital firm based in Portola Valley, US, founded in 2012. It led 2 of the 6 rounds it joined. Its most recent investment on record is Amber Therapeutics's $100M Series A round in July 2026, alongside NEA, 8VC, Intuitive Ventures and 2 others. By category, its portfolio leans toward Health and bio (4) and Manufacturing and industrial (1). It has co-invested with NEA, Gilde Healthcare and 8VC, most often NEA (3 rounds).
About Lightstone Ventures
Funds raised
| Fund | Fund # | Size | Announced |
|---|---|---|---|
Bay Area | Ifirst fund | $172M | xconomy.com |
What Lightstone Ventures invests in
- Health and bio · 4 · 100%
- Manufacturing and industrial · 1 · 25%
Lightstone Ventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A · $100M | NEA (lead), 8VC, Intuitive Ventures +2 | ||
| Series A · $47.5M · lead | Eurofarma, Samsara Biocapital (lead), YK Bioventures +1 | ||
| Series B+ · $80M | Gilde Healthcare, MVM Life Science Partners (lead), Ireland Strategic Investment Fund +2 | ||
| Series A · $100M | NEA (lead), 8VC, Intuitive Ventures +2 | ||
| Series A · $65M | Meneldor, Gilde Healthcare (lead), Novartis Venture Fund +3 | ||
| Series A · $34.01M · lead | Gilde Healthcare (lead), Atlantic Bridge University Fund, Ascentifi |
How Lightstone Ventures invests
Lightstone Ventures portfolio companies
AAmber Therapeutics$100MSeries A · Jul 2026
PPsiThera$47.5MSeries A · Dec 2025
PProVerum$80MSeries B+ · Aug 2025
TTagworks Pharmaceuticals$65MSeries A · Jun 2023
| Company | Round with Lightstone Ventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $100M | $200M | Jul 24, 2026 Series A |
Health and bio |
Series A · $47.5M · lead | $47.5M | Dec 16, 2025 Series A |
Health and bio |
Series B+ · $80M | $118.16M | Aug 25, 2025 Series B+ |
Health and bio |
Series A · $65M | $65M | Jun 22, 2023 Series A |
Most frequent co-investors
NNEA3 shared rounds · last Jul 24, 2026
GGilde Healthcare3 shared rounds · last Aug 25, 2025
88VC2 shared rounds · last Jul 24, 2026
FF-Prime Capital2 shared rounds · last Jul 24, 2026
OOxford Science Enterprises2 shared rounds · last Jul 24, 2026
IIntuitive Ventures2 shared rounds · last Jul 24, 2026
AAtlantic Bridge University Fund2 shared rounds · last Aug 25, 2025
SSamsara Biocapital1 shared round · last Dec 16, 2025
EEurofarma1 shared round · last Dec 16, 2025
YYK Bioventures1 shared round · last Dec 16, 2025
RRoivant Sciences1 shared round · last Dec 16, 2025
OOrbiMed1 shared round · last Aug 25, 2025
Similar investors
AAble Partners4 companies · 1 deal in 12 mo
GGenoa Ventures5 companies · 4 deals in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
CCatalyst Health Ventures5 companies · 3 deals in 12 mo
NNPIF – Mercia Equity Finance5 companies · 3 deals in 12 mo
VVirginia Innovation Partnership Corporation5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Venture funds Lightstone Ventures raised, from the list of new VC funds compiled by Shai Goldman (Brex). Each size links to the article that states it, or to that list where no article was found. All new funds: new VC funds.
Share is of the 6 rounds on Recent Funding that name Lightstone Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Lightstone Ventures, which is a subset of its real portfolio. API: /api/v1/investors/lightstone-ventures (get a free API key). More: the most active VC firms and new venture capital funds.